$REGN Company News 10 rock-solid stocks for co
Post# of 88914
Posted On: 09/25/2014 10:33:52 AM
$REGN Company News
10 rock-solid stocks for conservative investors 9:51 a.m. Sept. 17, 2014 - Philip van Doorn
S&P 500 nails the breakout point 10:35 a.m. Sept. 8, 2014 - Michael Ashbaugh
Regeneron shares run up 4.8% to lead S&P 500 gainers 9:34 a.m. Sept. 2, 2014 - Tomi Kilgore
Small health companies see large gains on a big earnings day 5:34 p.m. July 30, 2014 - Russ Britt
Twitter, U.S. Steel soar; Buffalo Wild Wings are burned 4:26 p.m. July 30, 2014 - Sue Chang
Edwards, Hospira rise as health-care companies see strong earnings 1:08 p.m. July 30, 2014 - Russ Britt
Regeneron shares jump after cholesterol drug meets test goals 11:16 a.m. July 30, 2014 - Russ Britt
Regeneron Pharmaceuticals jumps 7.7% 9:32 a.m. July 30, 2014 - Sue Chang
Dow ends at record high close but still shy of 17,000: Stock market live blog recap 4:04 p.m. July 1, 2014 - blogs.marketwatch.com
Twitter gains on new CFO; GM sales up in June 2:29 p.m. July 1, 2014 - Sue Chang
Oracle slides on disappointing results; CarMax soars 4:17 p.m. June 20, 2014 - Sue Chang
Maybe Amazon will unveil a toaster today 8:08 a.m. June 18, 2014 - Marek Fuchs
Twitter rallies ahead of earnings; 3D Systems retreats 3:49 p.m. April 29, 2014 - Sue Chang
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
First Solar, H-P, Symantec are stocks to watch 4:16 p.m. March 21, 2014 - Sue Chang
First Solar extends winning streak; Symantec plunges 3:07 p.m. March 21, 2014 - Sue Chang
Nasdaq falls for 4th day in row; Dow, S&P slip for 2nd day: stock market live blog recap 3:51 p.m. March 11, 2014 - blogs.marketwatch.com
Bull market’s biggest winners and losers 7:00 a.m. March 10, 2014 - Jeff Reeves
Lorillard and Reynolds jump on buyout report 5:16 p.m. March 3, 2014 - Sue Chang
Jim Cramer's 'Mad Money' Recap: Why You Can't Get Too Negative in This Market 8:24 p.m. Sept. 24, 2014 - TheStreet.com
Acorda To Buy Civitas, Gains Parkinson's Disease Drug 12:27 p.m. Sept. 24, 2014 - Investors Business Daily
Biotech Stock Roundup: Auxilium an Acquisition Target, Amgen Submits another BLA - Analyst Blog 11:05 a.m. Sept. 24, 2014 - Zacks.com
Anacor's Kerydin Launched in the US for Onychomycosis - Analyst Blog 5:05 p.m. Sept. 23, 2014 - Zacks.com
Bayer/Regeneron Successfully Expand Eylea Label in Japan - Analyst Blog 4:45 p.m. Sept. 23, 2014 - Zacks.com
Japanese health regulator approves Eylea label expansion 7:46 a.m. Sept. 22, 2014 - Seeking Alpha
Regeneron Is Regenerating Growth In My Portfolio Once Again 5:32 p.m. Sept. 21, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 9/19/14: REGN, ULTA, AFB, RLYP 1:57 p.m. Sept. 19, 2014 - Seeking Alpha
Friending Facebook To The Growth Portfolio In Replace Of Regeneron 10:11 a.m. Sept. 18, 2014 - Seeking Alpha
UPDATE: Morgan Stanley Reiterates On Regeneron Pharmaceuticals Inc Following DME Doc Event 9:51 a.m. Sept. 18, 2014 - benzinga.com
Regeneron Gets Breakthrough Therapy Status for Eylea - Analyst Blog 4:30 p.m. Sept. 17, 2014 - Zacks.com
InsiderInsights.com Daily Round Up 9/17/14: HTWR, REGN, IO, HALO 11:01 a.m. Sept. 17, 2014 - Seeking Alpha
Stock Market News for September 17, 2014 - Market News 10:10 a.m. Sept. 17, 2014 - Zacks.com
BTD tag for Eylea for diabetic retinopathy in DME 7:33 a.m. Sept. 16, 2014 - Seeking Alpha
'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks 5:00 a.m. Sept. 16, 2014 - TheStreet.com
Stock Market News for September 11, 2014 - Market News 10:10 a.m. Sept. 11, 2014 - Zacks.com
Trading Guidelines for Amgen, Biogen Idec, Gilead, 3 Other Biotechs 10:02 a.m. Sept. 11, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: This Is Why Apple Rules 8:10 p.m. Sept. 10, 2014 - TheStreet.com
Two Promising Gene Therapy Stocks Tackling Eye Disease 9:04 a.m. Sept. 9, 2014 - TheStreet.com
Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015 7:44 a.m. Sept. 9, 2014 - 247WallSt.com
Regulatory Approvals, Senior Notes Redemption, and Technical Updates - Research Reports on Tekmira, Regeneron, Valeant, Teva and United Therapeutics 9:20 a.m. Today - PR Newswire - PRF
Regeneron Announces EYLEA® (aflibercept) Injection Approved for the Treatment of Patients with Myopic Choroidal Neovascularization (CNV) in Japan 2:30 a.m. Sept. 22, 2014 - PR Newswire - PRF
EYLEA® (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema 7:00 a.m. Sept. 16, 2014 - PR Newswire - PRF
Biotech Stocks Under Review -- Keryx Biopharma, Sangamo BioSciences, Regeneron Pharma, Sunesis Pharma, and Idera Pharma 9:10 a.m. Sept. 9, 2014 - PR Newswire - PRF
Critical Alerts For Rocket Fuel, General Motors, International Business Machines, Google and Regeneron Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Sept. 8, 2014 - PR Newswire - PRF
MAA Filing, Acceptance of ANDA Filing, Earnings Release, Study Results and Recognition - Research Reports on Regeneron, Mylan, Toll Brothers, 3M and Eaton 9:00 a.m. Sept. 8, 2014 - PR Newswire - PRF
Regeneron Announces Submission of Application for EYLEA® (aflibercept) Injection in Japan for Macular Edema Following Branch Retinal Vein Occlusion 3:00 a.m. Sept. 4, 2014 - PR Newswire - PRF
Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014 3:00 a.m. Aug. 31, 2014 - PR Newswire - PRF
Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014 3:00 a.m. Aug. 31, 2014 - PR Newswire - PRF
Upcoming Conferences Schedule, Clinical Trial Data Release Schedule, Milestone Payment, and Expansion of Partnership - Research Reports on Celgene, Actavis, Regeneron, ISIS and UnitedHealth 9:10 a.m. Aug. 29, 2014 - PR Newswire - PRF
Appointments, Market Activity, Regulatory Approvals, and Rights Acquisition - Research Reports on Nike, Morgan Stanley, Regeneron, Zimmer and Jazz 9:00 a.m. Aug. 21, 2014 - PR Newswire - PRF
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) to Ring The NASDAQ Stock Market Opening Bell 10:01 a.m. Aug. 19, 2014 - GlobeNewswire
Global Uveitis Market 2014-2018.pdf 2:38 p.m. Aug. 12, 2014 - PR Newswire - PRF
Financial Results, Study Results, and Proposed Merger - Research Reports on Mallinckrodt, Thoratec, WellPoint, Questcor and Regeneron 8:40 a.m. Aug. 12, 2014 - PR Newswire - PRF
EYLEA® (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME) 2:30 a.m. Aug. 11, 2014 - PR Newswire - PRF
Regeneron Reports Second Quarter 2014 Financial and Operating Results 6:30 a.m. Aug. 5, 2014 - PR Newswire - PRF
Robbins Arroyo LLP Is Investigating the Officers and Directors of Regeneron Pharmaceuticals, Inc. on Behalf of Shareholders 1:30 p.m. Aug. 4, 2014 - PR Newswire - PRF
BioMarin Sells Priority Review Voucher for $67.5 Million 4:02 p.m. July 30, 2014 - GlobeNewswire
Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4:01 p.m. July 30, 2014 - PR Newswire - PRF
Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8:00 a.m. July 30, 2014 - PR Newswire - PRF
10 rock-solid stocks for conservative investors 9:51 a.m. Sept. 17, 2014 - Philip van Doorn
S&P 500 nails the breakout point 10:35 a.m. Sept. 8, 2014 - Michael Ashbaugh
Regeneron shares run up 4.8% to lead S&P 500 gainers 9:34 a.m. Sept. 2, 2014 - Tomi Kilgore
Small health companies see large gains on a big earnings day 5:34 p.m. July 30, 2014 - Russ Britt
Twitter, U.S. Steel soar; Buffalo Wild Wings are burned 4:26 p.m. July 30, 2014 - Sue Chang
Edwards, Hospira rise as health-care companies see strong earnings 1:08 p.m. July 30, 2014 - Russ Britt
Regeneron shares jump after cholesterol drug meets test goals 11:16 a.m. July 30, 2014 - Russ Britt
Regeneron Pharmaceuticals jumps 7.7% 9:32 a.m. July 30, 2014 - Sue Chang
Dow ends at record high close but still shy of 17,000: Stock market live blog recap 4:04 p.m. July 1, 2014 - blogs.marketwatch.com
Twitter gains on new CFO; GM sales up in June 2:29 p.m. July 1, 2014 - Sue Chang
Oracle slides on disappointing results; CarMax soars 4:17 p.m. June 20, 2014 - Sue Chang
Maybe Amazon will unveil a toaster today 8:08 a.m. June 18, 2014 - Marek Fuchs
Twitter rallies ahead of earnings; 3D Systems retreats 3:49 p.m. April 29, 2014 - Sue Chang
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
First Solar, H-P, Symantec are stocks to watch 4:16 p.m. March 21, 2014 - Sue Chang
First Solar extends winning streak; Symantec plunges 3:07 p.m. March 21, 2014 - Sue Chang
Nasdaq falls for 4th day in row; Dow, S&P slip for 2nd day: stock market live blog recap 3:51 p.m. March 11, 2014 - blogs.marketwatch.com
Bull market’s biggest winners and losers 7:00 a.m. March 10, 2014 - Jeff Reeves
Lorillard and Reynolds jump on buyout report 5:16 p.m. March 3, 2014 - Sue Chang
Jim Cramer's 'Mad Money' Recap: Why You Can't Get Too Negative in This Market 8:24 p.m. Sept. 24, 2014 - TheStreet.com
Acorda To Buy Civitas, Gains Parkinson's Disease Drug 12:27 p.m. Sept. 24, 2014 - Investors Business Daily
Biotech Stock Roundup: Auxilium an Acquisition Target, Amgen Submits another BLA - Analyst Blog 11:05 a.m. Sept. 24, 2014 - Zacks.com
Anacor's Kerydin Launched in the US for Onychomycosis - Analyst Blog 5:05 p.m. Sept. 23, 2014 - Zacks.com
Bayer/Regeneron Successfully Expand Eylea Label in Japan - Analyst Blog 4:45 p.m. Sept. 23, 2014 - Zacks.com
Japanese health regulator approves Eylea label expansion 7:46 a.m. Sept. 22, 2014 - Seeking Alpha
Regeneron Is Regenerating Growth In My Portfolio Once Again 5:32 p.m. Sept. 21, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 9/19/14: REGN, ULTA, AFB, RLYP 1:57 p.m. Sept. 19, 2014 - Seeking Alpha
Friending Facebook To The Growth Portfolio In Replace Of Regeneron 10:11 a.m. Sept. 18, 2014 - Seeking Alpha
UPDATE: Morgan Stanley Reiterates On Regeneron Pharmaceuticals Inc Following DME Doc Event 9:51 a.m. Sept. 18, 2014 - benzinga.com
Regeneron Gets Breakthrough Therapy Status for Eylea - Analyst Blog 4:30 p.m. Sept. 17, 2014 - Zacks.com
InsiderInsights.com Daily Round Up 9/17/14: HTWR, REGN, IO, HALO 11:01 a.m. Sept. 17, 2014 - Seeking Alpha
Stock Market News for September 17, 2014 - Market News 10:10 a.m. Sept. 17, 2014 - Zacks.com
BTD tag for Eylea for diabetic retinopathy in DME 7:33 a.m. Sept. 16, 2014 - Seeking Alpha
'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks 5:00 a.m. Sept. 16, 2014 - TheStreet.com
Stock Market News for September 11, 2014 - Market News 10:10 a.m. Sept. 11, 2014 - Zacks.com
Trading Guidelines for Amgen, Biogen Idec, Gilead, 3 Other Biotechs 10:02 a.m. Sept. 11, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: This Is Why Apple Rules 8:10 p.m. Sept. 10, 2014 - TheStreet.com
Two Promising Gene Therapy Stocks Tackling Eye Disease 9:04 a.m. Sept. 9, 2014 - TheStreet.com
Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015 7:44 a.m. Sept. 9, 2014 - 247WallSt.com
Regulatory Approvals, Senior Notes Redemption, and Technical Updates - Research Reports on Tekmira, Regeneron, Valeant, Teva and United Therapeutics 9:20 a.m. Today - PR Newswire - PRF
Regeneron Announces EYLEA® (aflibercept) Injection Approved for the Treatment of Patients with Myopic Choroidal Neovascularization (CNV) in Japan 2:30 a.m. Sept. 22, 2014 - PR Newswire - PRF
EYLEA® (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema 7:00 a.m. Sept. 16, 2014 - PR Newswire - PRF
Biotech Stocks Under Review -- Keryx Biopharma, Sangamo BioSciences, Regeneron Pharma, Sunesis Pharma, and Idera Pharma 9:10 a.m. Sept. 9, 2014 - PR Newswire - PRF
Critical Alerts For Rocket Fuel, General Motors, International Business Machines, Google and Regeneron Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Sept. 8, 2014 - PR Newswire - PRF
MAA Filing, Acceptance of ANDA Filing, Earnings Release, Study Results and Recognition - Research Reports on Regeneron, Mylan, Toll Brothers, 3M and Eaton 9:00 a.m. Sept. 8, 2014 - PR Newswire - PRF
Regeneron Announces Submission of Application for EYLEA® (aflibercept) Injection in Japan for Macular Edema Following Branch Retinal Vein Occlusion 3:00 a.m. Sept. 4, 2014 - PR Newswire - PRF
Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014 3:00 a.m. Aug. 31, 2014 - PR Newswire - PRF
Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014 3:00 a.m. Aug. 31, 2014 - PR Newswire - PRF
Upcoming Conferences Schedule, Clinical Trial Data Release Schedule, Milestone Payment, and Expansion of Partnership - Research Reports on Celgene, Actavis, Regeneron, ISIS and UnitedHealth 9:10 a.m. Aug. 29, 2014 - PR Newswire - PRF
Appointments, Market Activity, Regulatory Approvals, and Rights Acquisition - Research Reports on Nike, Morgan Stanley, Regeneron, Zimmer and Jazz 9:00 a.m. Aug. 21, 2014 - PR Newswire - PRF
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) to Ring The NASDAQ Stock Market Opening Bell 10:01 a.m. Aug. 19, 2014 - GlobeNewswire
Global Uveitis Market 2014-2018.pdf 2:38 p.m. Aug. 12, 2014 - PR Newswire - PRF
Financial Results, Study Results, and Proposed Merger - Research Reports on Mallinckrodt, Thoratec, WellPoint, Questcor and Regeneron 8:40 a.m. Aug. 12, 2014 - PR Newswire - PRF
EYLEA® (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME) 2:30 a.m. Aug. 11, 2014 - PR Newswire - PRF
Regeneron Reports Second Quarter 2014 Financial and Operating Results 6:30 a.m. Aug. 5, 2014 - PR Newswire - PRF
Robbins Arroyo LLP Is Investigating the Officers and Directors of Regeneron Pharmaceuticals, Inc. on Behalf of Shareholders 1:30 p.m. Aug. 4, 2014 - PR Newswire - PRF
BioMarin Sells Priority Review Voucher for $67.5 Million 4:02 p.m. July 30, 2014 - GlobeNewswire
Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4:01 p.m. July 30, 2014 - PR Newswire - PRF
Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8:00 a.m. July 30, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼